{
    "2021-09-24": [
        [
            {
                "time": "",
                "original_text": "凯莱英赴港二次上市获批 新业务高速增长收入增144.62%",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "赴港二次上市",
                        "获批",
                        "新业务",
                        "高速增长",
                        "收入增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}